Nephraegis Therapeutics

0 followers


Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).

Employees

1-10

Links

Org chart

Bryan F. Cox

Collapse
Jim Stolzenbach
Chief Development officer
Richard Marshak
Chief Commercial Officer

Teams

This company has no teams yet